CD4 and neoplasm: Accordingly, TCR-transgenic mice with large tumors (T), had significantly reduced numbers of Id-specific (GB113 positive) DP (CD4+CD8+) and SP CD4+ thymocytes compared to tumor-free (TF) as well as unchallenged (UC) mice.